High cholesterol is a growing concern for many people, as it increases the risk of heart disease and other health problems.
Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.
A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...
Commonly used prescription medications have a post-lanosterol biosynthesis inhibiting effect. Pathogenic variants in the DHCR7 gene result in SLOS ...
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
20h
News Medical on MSNExploring how 25-hydroxycholesterol triggers ferroptosis in glial cellsOxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis.
Supplement companies that make green tea extract promote weight-loss claims, but also that their pills, powders, and potions ...
After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder
The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...
A doctor has dispelled some prevalent myths surrounding cholesterol, highlighting the importance of carrying out regular ...
Beckham has repeatedly credited this simple ingredient as a game-changer for her health and overall well-being. In 2017, she ...
Scientists have found that an increase in water salinity in the cells of the marine diatom Nitzschia weakens the connections between the components of the photosynthetic apparatus and disrupts the ...
More than a seasonal flavor, pumpkin spice offers health benefits that support digestion, heart health, and blood sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results